Natco Pharma invests additional $14 million in biotech firm eGenesis
Drugmaker Natco Pharma is investing an additional $14 million in US-based biotechnology company eGenesis, which is developing genetically engineered organs for transplantation. The investment will be made through convertible promissory notes by…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.